NESs designed to lack the ADK gene showed a significant elevation of adenosine production in vitro, indicating that these genetically engineered NESs may serve as useful adenosine carriers, mitigating abnormal adenosine homeostasis in epilepsy (Poppe et al., 2018). Here, ADK is linked to epilepsy.